Last updated: 1 August 2024 at 4:36pm EST

Geoffrey Michael Glass Net Worth




The estimated Net Worth of Geoffrey Michael Glass is at least $805 Mille dollars as of 10 August 2023. Geoffrey Glass owns over 14,000 units of Avadel Pharmaceuticals plc stock worth over $805,350 and over the last 6 years Geoffrey sold AVDL stock worth over $0.

Geoffrey Glass AVDL stock SEC Form 4 insiders trading

Geoffrey has made over 5 trades of the Avadel Pharmaceuticals plc stock since 2019, according to the Form 4 filled with the SEC. Most recently Geoffrey bought 14,000 units of AVDL stock worth $187,600 on 10 August 2023.

The largest trade Geoffrey's ever made was buying 45,000 units of Avadel Pharmaceuticals plc stock on 1 June 2022 worth over $96,300. On average, Geoffrey trades about 6,050 units every 85 days since 2018. As of 10 August 2023 Geoffrey still owns at least 59,000 units of Avadel Pharmaceuticals plc stock.

You can see the complete history of Geoffrey Glass stock trades at the bottom of the page.



What's Geoffrey Glass's mailing address?

Geoffrey's mailing address filed with the SEC is C/O AVADEL PHARMACEUTICALS PLC, 10 EARLSFORT TERRACE, DUBLIN 2, L2, D02 T380.

Insiders trading at Avadel Pharmaceuticals plc

Over the last 8 years, insiders at Avadel Pharmaceuticals plc have traded over $7,791,038 worth of Avadel Pharmaceuticals plc stock and bought 775,568 units worth $4,366,224 . The most active insiders traders include Healthcare Master Fund Ltd ..., Kevin Broadfin Capital, Llc... e Naseem Amin. On average, Avadel Pharmaceuticals plc executives and independent directors trade stock every 43 days with the average trade being worth of $381,436. The most recent stock trade was executed by Thomas S Mchugh on 16 January 2024, trading 2,000 units of AVDL stock currently worth $29,000.



What does Avadel Pharmaceuticals plc do?

avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.



What does Avadel Pharmaceuticals plc's logo look like?

Avadel Pharmaceuticals plc logo

Complete history of Geoffrey Glass stock trades at Avadel Pharmaceuticals plc

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
10 Aug 2023 Geoffrey Michael Glass
Direttore
Acquistare 14,000 $13.40 $187,600
10 Aug 2023
59,000
1 Jun 2022 Geoffrey Michael Glass
Direttore
Acquistare 45,000 $2.14 $96,300
1 Jun 2022
45,000
28 Aug 2020 Geoffrey Michael Glass
Direttore
Acquistare 4,800 $6.78 $32,544
28 Aug 2020
65,700
12 Aug 2020 Geoffrey Michael Glass
Direttore
Acquistare 13,000 $7.73 $100,490
12 Aug 2020
60,900
15 Nov 2019 Geoffrey Michael Glass
Direttore
Acquistare 20,000 $4.99 $99,800
15 Nov 2019
47,900


Avadel Pharmaceuticals plc executives and stock owners

Avadel Pharmaceuticals plc executives and other stock owners filed with the SEC include: